Sun Pharma Q3 PAT seen up 43% at Rs 456 cr

21963 Investors following Sun Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Sun Pharma Q3 PAT seen up 43% at Rs 456 cr

Sun Pharma is to announce its third quarter results. According to CNBC-TV18 estimates, the company's Q3FY09 consolidated net sales are seen up 42% at Rs 1140 crore versus Rs 803 crore, YoY.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ News and Notices about Sun Pharma See interviews with Sun Pharma Management See what other Experts & Brokerages are saying about Sun Pharma See previous Results of Sun Pharma Sun Pharma BSE | NSE 25/05/12 Are Mutual Funds betting on Sun Pharma?

Sun Pharma is to announce its third quarter results. According to CNBC-TV18 estimates, the company's Q3FY09 consolidated net sales are seen up 42% at Rs 1140 crore versus Rs 803 crore, YoY.

Its net profit is expected to go up 43% at Rs 456 crore versus Rs 318 crore.

Its operating profits is seen up at Rs 497 crore verssu Rs 354 crore.

The company's OPM is seen dwon 43.68% versus 44%.

Factors to watch for:

Protonix exclusivity  to boost sales growth

Company has no debt &  no hedged positions,  Should also benefit from Rupee depreciation in Qtr

With Out Protonix launch top line is expected to grow 14% 

EBIDTA margins to  ease  because Q3FY08 saw launch of Trileptal